No changes in myocardial perfusion following radiation therapy of left-sided breast cancer: A positron emission tomography study

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

No changes in myocardial perfusion following radiation therapy of left-sided breast cancer : A positron emission tomography study. / Rasmussen, Thomas; Kjær, Andreas; Lassen, Martin Lyngby; Pedersen, Anders Navrsted; Specht, Lena; Aznar, Marianne C.; Hasbak, Philip.

In: Journal of Nuclear Cardiology, Vol. 28, 2021, p. 1923–1932.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Rasmussen, T, Kjær, A, Lassen, ML, Pedersen, AN, Specht, L, Aznar, MC & Hasbak, P 2021, 'No changes in myocardial perfusion following radiation therapy of left-sided breast cancer: A positron emission tomography study', Journal of Nuclear Cardiology, vol. 28, pp. 1923–1932. https://doi.org/10.1007/s12350-019-01949-9

APA

Rasmussen, T., Kjær, A., Lassen, M. L., Pedersen, A. N., Specht, L., Aznar, M. C., & Hasbak, P. (2021). No changes in myocardial perfusion following radiation therapy of left-sided breast cancer: A positron emission tomography study. Journal of Nuclear Cardiology, 28, 1923–1932. https://doi.org/10.1007/s12350-019-01949-9

Vancouver

Rasmussen T, Kjær A, Lassen ML, Pedersen AN, Specht L, Aznar MC et al. No changes in myocardial perfusion following radiation therapy of left-sided breast cancer: A positron emission tomography study. Journal of Nuclear Cardiology. 2021;28:1923–1932. https://doi.org/10.1007/s12350-019-01949-9

Author

Rasmussen, Thomas ; Kjær, Andreas ; Lassen, Martin Lyngby ; Pedersen, Anders Navrsted ; Specht, Lena ; Aznar, Marianne C. ; Hasbak, Philip. / No changes in myocardial perfusion following radiation therapy of left-sided breast cancer : A positron emission tomography study. In: Journal of Nuclear Cardiology. 2021 ; Vol. 28. pp. 1923–1932.

Bibtex

@article{20e1df1bbabd40f8a70daf4530446459,
title = "No changes in myocardial perfusion following radiation therapy of left-sided breast cancer: A positron emission tomography study",
abstract = "Background: Adjuvant radiation therapy (RT) for breast cancer has improved overall survival. However, incidental exposure of the heart has been linked to development of radiation-induced heart disease. The aim of this study was, in a cohort of asymptomatic post-irradiation breast cancer patients, to investigate changes in myocardial blood flow (MBF) and presence of perfusion defects in myocardial perfusion positron-emission-tomography (PET) in the irradiated myocardium. Methods and Results: Twenty patients treated with RT for left-sided breast cancer underwent 13N-ammonia myocardial perfusion PET 7(± 2) years after breath adapted RT to a total dose of 48 Gy given in 24 fractions. No differences in rest or stress MBF were noted between the irradiated and non-irradiated myocardium (1.29 (± 0.29) vs 1.33 (± 0.29) mL/g/min, ns; 2.74 (± 0.59) vs 2.78 (± 0.66) mL/g/min, ns, respectively). One patient demonstrated a myocardial perfusion defect localized in the irradiated anterior wall myocardium. Conclusion: Although limited by a small sample size, early signs of cardiac injury detected by NH3 myocardial perfusion PET was at least not frequent in our cohort of patients treated with a modern RT technique for left-sided breast cancer, even 7 years after treatment. The findings however, may not rule out subsequent development of myocardial injury.",
keywords = "ammonia cardiac PET, breast cancer, cardiac positron-emission-tomography, Myocardial perfusion, radiation therapy",
author = "Thomas Rasmussen and Andreas Kj{\ae}r and Lassen, {Martin Lyngby} and Pedersen, {Anders Navrsted} and Lena Specht and Aznar, {Marianne C.} and Philip Hasbak",
year = "2021",
doi = "10.1007/s12350-019-01949-9",
language = "English",
volume = "28",
pages = "1923–1932",
journal = "Journal of Nuclear Cardiology",
issn = "1071-3581",
publisher = "Springer",

}

RIS

TY - JOUR

T1 - No changes in myocardial perfusion following radiation therapy of left-sided breast cancer

T2 - A positron emission tomography study

AU - Rasmussen, Thomas

AU - Kjær, Andreas

AU - Lassen, Martin Lyngby

AU - Pedersen, Anders Navrsted

AU - Specht, Lena

AU - Aznar, Marianne C.

AU - Hasbak, Philip

PY - 2021

Y1 - 2021

N2 - Background: Adjuvant radiation therapy (RT) for breast cancer has improved overall survival. However, incidental exposure of the heart has been linked to development of radiation-induced heart disease. The aim of this study was, in a cohort of asymptomatic post-irradiation breast cancer patients, to investigate changes in myocardial blood flow (MBF) and presence of perfusion defects in myocardial perfusion positron-emission-tomography (PET) in the irradiated myocardium. Methods and Results: Twenty patients treated with RT for left-sided breast cancer underwent 13N-ammonia myocardial perfusion PET 7(± 2) years after breath adapted RT to a total dose of 48 Gy given in 24 fractions. No differences in rest or stress MBF were noted between the irradiated and non-irradiated myocardium (1.29 (± 0.29) vs 1.33 (± 0.29) mL/g/min, ns; 2.74 (± 0.59) vs 2.78 (± 0.66) mL/g/min, ns, respectively). One patient demonstrated a myocardial perfusion defect localized in the irradiated anterior wall myocardium. Conclusion: Although limited by a small sample size, early signs of cardiac injury detected by NH3 myocardial perfusion PET was at least not frequent in our cohort of patients treated with a modern RT technique for left-sided breast cancer, even 7 years after treatment. The findings however, may not rule out subsequent development of myocardial injury.

AB - Background: Adjuvant radiation therapy (RT) for breast cancer has improved overall survival. However, incidental exposure of the heart has been linked to development of radiation-induced heart disease. The aim of this study was, in a cohort of asymptomatic post-irradiation breast cancer patients, to investigate changes in myocardial blood flow (MBF) and presence of perfusion defects in myocardial perfusion positron-emission-tomography (PET) in the irradiated myocardium. Methods and Results: Twenty patients treated with RT for left-sided breast cancer underwent 13N-ammonia myocardial perfusion PET 7(± 2) years after breath adapted RT to a total dose of 48 Gy given in 24 fractions. No differences in rest or stress MBF were noted between the irradiated and non-irradiated myocardium (1.29 (± 0.29) vs 1.33 (± 0.29) mL/g/min, ns; 2.74 (± 0.59) vs 2.78 (± 0.66) mL/g/min, ns, respectively). One patient demonstrated a myocardial perfusion defect localized in the irradiated anterior wall myocardium. Conclusion: Although limited by a small sample size, early signs of cardiac injury detected by NH3 myocardial perfusion PET was at least not frequent in our cohort of patients treated with a modern RT technique for left-sided breast cancer, even 7 years after treatment. The findings however, may not rule out subsequent development of myocardial injury.

KW - ammonia cardiac PET

KW - breast cancer

KW - cardiac positron-emission-tomography

KW - Myocardial perfusion

KW - radiation therapy

U2 - 10.1007/s12350-019-01949-9

DO - 10.1007/s12350-019-01949-9

M3 - Journal article

C2 - 31741325

AN - SCOPUS:85075233536

VL - 28

SP - 1923

EP - 1932

JO - Journal of Nuclear Cardiology

JF - Journal of Nuclear Cardiology

SN - 1071-3581

ER -

ID: 241091765